跳至主要内容
临床试验/NCT00442143
NCT00442143Unknown1 期

Treatment of Severe Limb Ischemia With Autologous Bonemarrow Derived Mononuclear Cells

Odense University Hospital2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2007年1月最近更新:
适应症

试验速览

阶段
1 期
入组人数
10
试验地点
2
主要终点
Transcutaneous oxygen pressure

研究概览

简要总结

The aim of the study is to investigate whether implantation of autologous bone marrow derived stem cells in ishemics limbs will improve vascularization

详细描述

10 patients with severe lower limb ischemia will be included in this pilote trial.

Bonemarrow aspiration will be performed and and the monocuclear cells isolated an injected into the gastrocnemius.

The patiens are followed for 4 months. Were trancutaneous oxygenpressure, ankel and toe blood pressure is measured.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ankle blood pressure < 70 mmgHG
  • Either pain at rest and/or ischemic wound
  • No possible surgical treatment

排除标准

  • Infection
  • Malignant disease

结局指标

主要结局

Transcutaneous oxygen pressure

1st toe blood pressure (strain gauge)

Ankle blood pressure

Wound healing

Pain

次要结局

  • amputation
  • Infection

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验